Clinical trial

Trial Comparing Metformin Versus Placebo in Non Alcoholic Steatohepatitis (NASH)…

NCT00134303 · University Hospital, Ghent, Other · Completed

Key facts

NCT number NCT00134303
Title Trial Comparing Metformin Versus Placebo in Non Alcoholic Steatohepatitis (NASH) Patients Receiving Bariatric Surgery for Obesity
Official title Double Blinded Randomised Trial Comparing Metformin Versus Placebo in NASH Patients Receiving Bariatric Surgery for Obesity
Lead sponsor University Hospital, Ghent, Other
Collaborators Merck Sharp & Dohme LLC Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Obesity
Intervention type Drug
Interventions Metformin
Enrollment 65
Start date Jun 1, 2005
Primary completion Mar 31, 2006
Completion Mar 31, 2006
First posted Aug 24, 2005
Last update posted Dec 8, 2022
Countries Belgium

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies